Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group. [electronic resource]
Producer: 20100407Description: 694-702 p. digitalISSN:- 1545-5017
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- antagonists & inhibitors
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Child
- Child, Preschool
- Cyclosporins -- administration & dosage
- Drug Resistance, Multiple
- Drug-Related Side Effects and Adverse Reactions
- Etoposide -- administration & dosage
- Female
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Maximum Tolerated Dose
- Mitoxantrone -- administration & dosage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Recurrence
- Salvage Therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.